ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides ...
(RTTNews) - Aurora Cannabis Inc. (ACB.TO), a medical cannabis company based in Canada, Thursday has announced the discovery of a novel genetic resistance source against powdery mildew, known as PM2.
Hosted on MSN17d
Aurora makes breakthrough in cannabis mildew resistancea new source of genetic resistance for cannabis plants against powdery mildew ・The company is experimenting with powdery-mildew-resistant cultivars for a potential commercial launch in 2025 ...
Aurora Cannabis (ACB) is pleased to announce the company’s discovery of a novel source of genetic resistance against powdery mildew, PM2, that ...
EDMONTON, AB, March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's ...
EDMONTON, AB, March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of ...
ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results